Literature DB >> 31597448

Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease.

Annabelle Rodriguez1, Bernardo L Trigatti2, Chieko Mineo3, Darcy Knaack4, John T Wilkins5, Daisy Sahoo4,6, Bela F Asztalos7, Samia Mora8, Marina Cuchel9, Henry J Pownall10, Corina Rosales10, Pascal Bernatchez11, Amanda Ribeiro Martins da Silva12, Godfrey S Getz13, Jacob L Barber14, Gregory C Shearer15, Angela M Zivkovic16, Uwe J F Tietge17,18, Frank M Sacks19, Margery A Connelly20, Michael N Oda21, W Sean Davidson22, Mary G Sorci-Thomas6, Tomas Vaisar23, Giacomo Ruotolo24, Kasey C Vickers25, Catherine Martel26.   

Abstract

The HDL (high-density lipoprotein) Workshop was established in 2009 as a forum for candid discussions among academic basic scientists, clinical investigators, and industry researchers about the role of HDL in cardiovascular disease. This ninth HDL Workshop was held on May 16 to 17, 2019 in Boston, MA, and included outstanding oral presentations from established and emerging investigators. The Workshop featured 5 sessions with topics that tackled the role of HDL in the vasculature, its structural complexity, its role in health and disease states, and its interaction with the intestinal microbiome. The highlight of the program was awarding the Jack Oram Award to the distinguished professor emeritus G.S. Getz from the University of Chicago. The tenth HDL Workshop will be held on May 2020 in Chicago and will continue the focus on intellectually stimulating presentations by established and emerging investigators on novel roles of HDL in cardiovascular and noncardiovascular health and disease states.

Entities:  

Keywords:  American Heart Association; cardiovascular disease; cholesterol; health; lipoproteins

Mesh:

Substances:

Year:  2019        PMID: 31597448      PMCID: PMC6937204          DOI: 10.1161/ATVBAHA.119.313340

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  53 in total

1.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  Circulation       Date:  2018-11-10       Impact factor: 29.690

2.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Authors:  Amit V Khera; Marina Cuchel; Margarita de la Llera-Moya; Amrith Rodrigues; Megan F Burke; Kashif Jafri; Benjamin C French; Julie A Phillips; Megan L Mucksavage; Robert L Wilensky; Emile R Mohler; George H Rothblat; Daniel J Rader
Journal:  N Engl J Med       Date:  2011-01-13       Impact factor: 91.245

3.  Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).

Authors:  Amit V Khera; Olga V Demler; Steven J Adelman; Heidi L Collins; Robert J Glynn; Paul M Ridker; Daniel J Rader; Samia Mora
Journal:  Circulation       Date:  2017-04-27       Impact factor: 29.690

4.  Transintestinal and Biliary Cholesterol Secretion Both Contribute to Macrophage Reverse Cholesterol Transport in Rats-Brief Report.

Authors:  Jan Freark de Boer; Marleen Schonewille; Arne Dikkers; Martijn Koehorst; Rick Havinga; Folkert Kuipers; Uwe J F Tietge; Albert K Groen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-23       Impact factor: 8.311

5.  Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.

Authors:  Kristina K Durham; George Kluck; Kei Cheng Mak; Yak D Deng; Bernardo L Trigatti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-04-19       Impact factor: 4.733

6.  Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Authors:  Gregory G Schwartz; Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R Scott Wright
Journal:  N Engl J Med       Date:  2012-11-05       Impact factor: 91.245

7.  ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate.

Authors:  Bingqing Xu; Baiba K Gillard; Antonio M Gotto; Corina Rosales; Henry J Pownall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-10-26       Impact factor: 8.311

8.  Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT.

Authors:  Arne Dikkers; Jan Freark de Boer; Albert K Groen; Uwe J F Tietge
Journal:  Atherosclerosis       Date:  2015-10-08       Impact factor: 5.162

9.  Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies.

Authors:  Christian M Madsen; Anette Varbo; Børge G Nordestgaard
Journal:  Eur Heart J       Date:  2017-08-21       Impact factor: 29.983

10.  Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Nadia Milad; Zoe White; Arash Y Tehrani; Stephanie Sellers; Fabio M V Rossi; Pascal Bernatchez
Journal:  Skelet Muscle       Date:  2017-09-12       Impact factor: 4.912

View more
  3 in total

1.  Free fatty acid receptor 4 responds to endogenous fatty acids to protect the heart from pressure overload.

Authors:  Katherine A Murphy; Brian A Harsch; Chastity L Healy; Sonal S Joshi; Shue Huang; Rachel E Walker; Brandon M Wagner; Katherine M Ernste; Wei Huang; Robert C Block; Casey D Wright; Nathan Tintle; Brian C Jensen; Quinn S Wells; Gregory C Shearer; Timothy D O'Connell
Journal:  Cardiovasc Res       Date:  2022-03-16       Impact factor: 10.787

Review 2.  A Nutrigenetic Update on CETP Gene-Diet Interactions on Lipid-Related Outcomes.

Authors:  Ramatu Wuni; Gunter G C Kuhnle; Alexandra Azzari Wynn-Jones; Karani Santhanakrishnan Vimaleswaran
Journal:  Curr Atheroscler Rep       Date:  2022-01-31       Impact factor: 5.113

Review 3.  Coagulatory Defects in Type-1 and Type-2 Diabetes.

Authors:  Amélie I S Sobczak; Alan J Stewart
Journal:  Int J Mol Sci       Date:  2019-12-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.